Genetic analysis of inflammatory responses in wild-derived mice

野生小鼠炎症反应的遗传分析

基本信息

  • 批准号:
    8579867
  • 负责人:
  • 金额:
    $ 41.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-01 至 2016-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A central scientific question of this competing proposal's renewal is finding novel functions of immunologically relevant genes by means of classical genetic analysis in genetically diverse wild-derived mice. We have shown and continue to show that, with respect to regulation of immune responses, wild-derived mice resemble human phenotype better than classical laboratory mice. One line of inquiry continues investigation of TIRAP-dependent activation of IRAK2 followed by specific recruitment of the p38 MAP kinase, which is hyperactivated in wild- derived but not laboratory mice. We have proposed a model of MyD88-independent recruitment of IRAK2 and TIRAP in wild-derived mice, which leads to a specific activation of p38. If confirmed, this model will challenge several well-established paradigms such as simultaneous activation of MAP kinases via TLRs and MyD88- dependent activation of p38 thus broadening existing models of TLR-mediated activation and providing additional mechanistic insight. Another phenotype that we propose to investigate in wild-derived mice is their remarkable resistance to TNF-induced lethality, which is, according to our preliminary data, a genetic trait that is conferred by four loci, which we propose to identify. Given our expertise and track record in mapping and positional cloning, it is likely that we will find novel components of TNF-receptor pathway, which protect mice and presumably humans from TNF-induced lethality. To explain the trait, we generated our central hypothesis in that TNF-resistance in MSM mice is biased towards pro-survival as compared to cytotoxic signaling that leads to necrosis, and we provide feasible scientific plan to prove that. Thus, the scientific impact of this proposal is high because it will identify component, which are capable of defining the outcome of TNF-activation. In addition, the proposed genetic analysis will help identifying genes that otherwise would be difficult to predict in the absence of " strong educated guess". Most importantly, the identification of these genes will be of high relevance to human health given several hundred thousand of patients suffering each year from septic shock. In addition to cloning of the TNF-resistance, which is clearly a priority of this proposal, we provide a research plan aimed at revealing in vivo functions of two genes that we identified in the previous cycle. ) )
描述(由申请人提供):这项竞争性提案更新的一个中心科学问题是,通过在遗传多样性的野生来源小鼠中进行经典遗传分析,找到免疫相关基因的新功能。我们已经证明并将继续证明,就免疫反应的调节而言,野生来源的小鼠比经典的实验室小鼠更接近人类的表型。一条研究路线继续研究依赖于TIRAP的IRAK2的激活,随后是p38 MAP激酶的特定招募,它在野生来源的小鼠中高度激活,但在实验室小鼠中不是。我们已经提出了一种MyD88依赖的IRAK2和TIRAP在野生源小鼠中的募集模型,它导致了p38的特异性激活。如果得到证实,这个模型将挑战几个成熟的范例,例如通过TLRs同时激活MAP激酶和依赖MyD88激活p38,从而拓宽了TLR介导的激活的现有模型,并提供了额外的机制洞察力。我们计划在野生小鼠身上研究的另一个表型是它们对肿瘤坏死因子诱导的致死性的显著抵抗力,根据我们的初步数据,这是一种由四个基因座决定的遗传特征,我们建议对其进行鉴定。鉴于我们在定位和定位克隆方面的专业知识和记录,我们很可能会发现肿瘤坏死因子受体途径的新成分,它可以保护小鼠和可能的人类免受肿瘤坏死因子诱导的死亡。为了解释这一特征,我们提出了我们的中心假设,即与导致坏死的细胞毒信号相比,MSM小鼠的肿瘤坏死因子耐药倾向于支持生存,我们提供了可行的科学计划来证明这一点。因此,这一提议的科学影响很大,因为它将确定能够定义肿瘤坏死因子激活结果的成分。此外,拟议的基因分析将有助于识别在没有“强有力的有根据的猜测”的情况下难以预测的基因。最重要的是,鉴于每年有数十万感染性休克患者,这些基因的识别将与人类健康高度相关。除了克隆抗肿瘤坏死因子的基因,这显然是这项提议的优先事项,我们还提供了一项研究计划,旨在揭示我们在前一个周期中确定的两个基因在体内的功能。))

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Poltorak其他文献

Alexander Poltorak的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Poltorak', 18)}}的其他基金

Regulation of LPS-responses by ZBP1
ZBP1 对 LPS 反应的调节
  • 批准号:
    10389170
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Regulation of LPS-responses by ZBP1
ZBP1 对 LPS 反应的调节
  • 批准号:
    10492757
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Regulation of LPS-responses by ZBP1
ZBP1 对 LPS 反应的调节
  • 批准号:
    10840500
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Regulation of LPS-responses by ZBP1
ZBP1 对 LPS 反应的调节
  • 批准号:
    10808282
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Regulation of LPS-responses by ZBP1
ZBP1 对 LPS 反应的调节
  • 批准号:
    10686361
  • 财政年份:
    2021
  • 资助金额:
    $ 41.25万
  • 项目类别:
Activation of STING-mediated pathway(s) in T cells
T 细胞中 STING 介导的通路的激活
  • 批准号:
    9229505
  • 财政年份:
    2016
  • 资助金额:
    $ 41.25万
  • 项目类别:
Understanding genetic basis for resistance to TNF-induced lethal shock using new
使用新方法了解抵抗 TNF 诱导的致死性休克的遗传基础
  • 批准号:
    7978153
  • 财政年份:
    2010
  • 资助金额:
    $ 41.25万
  • 项目类别:
Understanding genetic basis for resistance to TNF-induced lethal shock using new
使用新方法了解抵抗 TNF 诱导的致死性休克的遗传基础
  • 批准号:
    8073126
  • 财政年份:
    2010
  • 资助金额:
    $ 41.25万
  • 项目类别:
Hyper-Responsiveness to TLR Agonists in Wild Derived Mice
野生小鼠对 TLR 激动剂的过度反应
  • 批准号:
    7683460
  • 财政年份:
    2008
  • 资助金额:
    $ 41.25万
  • 项目类别:
Genetic Analysis of Inflammatory Responses in Wild Derived Mice
野生小鼠炎症反应的遗传分析
  • 批准号:
    10534173
  • 财政年份:
    2003
  • 资助金额:
    $ 41.25万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 41.25万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 41.25万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 41.25万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 41.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 41.25万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 41.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了